These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 9688067

  • 1. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
    Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B.
    Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067
    [Abstract] [Full Text] [Related]

  • 2. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P, Corradin G, Merkle HP, Gander B.
    J Control Release; 1998 Dec 04; 56(1-3):209-17. PubMed ID: 9801444
    [Abstract] [Full Text] [Related]

  • 3. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
    Johansen P, Tamber H, Merkle HP, Gander B.
    Eur J Pharm Biopharm; 1999 May 04; 47(3):193-201. PubMed ID: 10382103
    [Abstract] [Full Text] [Related]

  • 4. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP.
    Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
    Johansen P, Moon L, Tamber H, Merkle HP, Gander B, Sesardic D.
    Vaccine; 1999 Sep 27; 18(3-4):209-15. PubMed ID: 10506644
    [Abstract] [Full Text] [Related]

  • 14. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T, Koneberg R, Hungerer KD, Kissel T.
    Int J Pharm; 2002 Mar 02; 234(1-2):75-90. PubMed ID: 11839439
    [Abstract] [Full Text] [Related]

  • 15. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M, Nolley J, Guo Y, McIver J, Alonso MJ.
    Pharm Res; 1999 May 02; 16(5):682-8. PubMed ID: 10350011
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.
    Johansen P, Estevez F, Zurbriggen R, Merkle HP, Glück R, Corradin G, Gander B.
    Vaccine; 2000 Dec 08; 19(9-10):1047-54. PubMed ID: 11137238
    [Abstract] [Full Text] [Related]

  • 18. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T.
    Pharm Res; 2001 Mar 08; 18(3):352-60. PubMed ID: 11442276
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
    Chang AC, Gupta RK.
    J Pharm Sci; 1996 Feb 08; 85(2):129-32. PubMed ID: 8683435
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.